SMTL ID : 4k26.1

4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

homo-dimer

Ligands

2 x SFF: (4aS,8aR)-N-cyclohexyl-4a,5,6,7,8,8a-hexahydro-4,1,2-benzoxathiazin-3-amine 1,1-dioxide(Non-covalent)

SFF.1: 15 residues within 4Å: Chain A: I.105, T.108, S.154, L.155, A.156, Q.161, I.164, Y.167, L.199, G.200, L.201, T.206, I.211, I.215 Ligands: NDP.4 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.105, A:I.164, A:L.201, A:T.206, A:I.211, A:I.215 Hydrogen bonds: A:S.154, A:L.155, A:A.156, A:Y.167, A:Y.167 Water bridges: A:L.201 SFF.5: 14 residues within 4Å: Chain B: I.105, T.108, S.154, L.155, A.156, Q.161, I.164, Y.167, L.199, G.200, L.201, I.211, I.215 Ligands: NDP.7 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:I.105, B:T.108, B:I.164, B:L.201, B:I.211, B:I.215 Hydrogen bonds: B:S.154, B:L.155, B:A.156, B:Y.167 Water bridges: B:L.201

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 6 residues within 4Å: Chain A: K.28, G.29, R.32, T.204, E.205, K.222 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:G.29, A:E.205 Water bridges: A:R.32, A:T.206, A:T.206, A:K.222 Salt bridges: A:R.32, A:K.222 SO4.3: 1 residues within 4Å: Chain A: R.32 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.32 SO4.6: 5 residues within 4Å: Chain B: R.50, T.106, Q.107, R.122 Ligands: NDP.7 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:T.106, B:T.106, B:Q.107 Salt bridges: B:R.50, B:R.122

2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.4: 28 residues within 4Å: Chain A: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, N.103, H.104, I.105, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: SFF.1 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:L.199, A:I.202 Hydrogen bonds: A:G.25, A:S.27, A:S.27, A:K.28, A:I.30, A:R.50, A:S.51, A:T.76, A:M.77, A:N.103, A:I.105, A:K.171, A:I.202, A:T.204 Water bridges: A:G.31, A:T.106, A:T.106, A:T.206, A:T.206 Salt bridges: A:K.28, A:R.50 NDP.7: 31 residues within 4Å: Chain B: G.25, A.26, S.27, K.28, G.29, I.30, A.49, R.50, S.51, G.75, T.76, M.77, N.103, H.104, I.105, R.122, Y.131, I.152, S.153, S.154, Y.167, K.171, L.199, G.200, L.201, I.202, T.204, T.206, A.207 Ligands: SFF.5, SO4.6 27 PLIP interactions: 27 interactions with chain B Hydrophobic interactions: B:L.199, B:I.202 Hydrogen bonds: B:G.25, B:S.27, B:S.27, B:K.28, B:I.30, B:R.50, B:S.51, B:T.76, B:T.76, B:M.77, B:N.103, B:I.105, B:R.122, B:Y.131, B:Y.167, B:K.171, B:I.202, B:T.204, B:T.204, B:T.206 Water bridges: B:G.29, B:G.31 Salt bridges: B:K.28, B:K.28, B:R.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bohme, T. et al., 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11-HSD1 inhibitors for the treatment of diabetes. Bioorg.Med.Chem.Lett. (2013)

Release Date

2014-04-09

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence